25.54 USD
▲-0.11+0.98%
盘后 25.15 -0.57%
2026-08-03
市值
—
规模 AUM
$5.07M
EPS
—
股息率
—
52 周区间
21.70 – 27.28
成交量
2.03K
Beta
0.38
目标价
—
52W 低 21.7052W 高 27.28
价格走势
公司简介
The Amplify Weight Loss Drug & Treatment ETF (THNR) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a modified market cap-weighted index of companies from developed markets that manufacture and enable GLP-1 agonist pharmaceutical businesses. THNR was launched on May 21, 2024 and is issued by Amplify Investments.